AR004781A1 - Derivados de 2-(sulfanil substituido)-3,5-dihidro-imidazol-4-ona y su uso en la preparacionn de medicamentos. - Google Patents
Derivados de 2-(sulfanil substituido)-3,5-dihidro-imidazol-4-ona y su uso en la preparacionn de medicamentos.Info
- Publication number
- AR004781A1 AR004781A1 ARP960105365A ARP960105365A AR004781A1 AR 004781 A1 AR004781 A1 AR 004781A1 AR P960105365 A ARP960105365 A AR P960105365A AR P960105365 A ARP960105365 A AR P960105365A AR 004781 A1 AR004781 A1 AR 004781A1
- Authority
- AR
- Argentina
- Prior art keywords
- carbon atoms
- medicines
- dihydro
- derivatives
- preparation
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical group NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- -1 2- (substituted sulfanyl) -3,5-dihydro-imidazol-4-one Chemical class 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 229920001774 Perfluoroether Polymers 0.000 abstract 1
- 125000005333 aroyloxy group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 230000036765 blood level Effects 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Derivados de 2-(sulfanil sustituido)-3,5-dihidro-imidazol-4-ona de fórmula (I), en donde R es fenilo o fenilo opcionalmente sustituido con uno o másgrupos seleccionados de halógeno, alquilo de 1 a 6 átomos de carbono, perfluoralquilo de 1a 6 átomos de carbono, alcoxi de 1 a 6 átomos de carbono,perfluoralcoxi de 1 a 6 átomos de carbono, hidroxi, alcanoiloxi de 2 a 6 átomos de carbono, aroiloxi de 7 a 11 átomos de carbono o arilaalcanoiloxi de 8 a 16átomos de carbono; R3 es alquilo de1 a 6 átomos de carbono, arilo de 6 a 10 átomos de carbono o arilalquilo de 7 a 12 átomos de carbono; o una salfarmacéuticamente aceptable del mismo, que se usan para incrementar los niveles sanguíneo de HDL y su uso en la preparación de medicamentos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US765395P | 1995-11-28 | 1995-11-28 | |
| US08/563,841 US5599829A (en) | 1995-11-28 | 1995-11-28 | 2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives for increasing HDL cholesterol levels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR004781A1 true AR004781A1 (es) | 1999-03-10 |
Family
ID=26677246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960105365A AR004781A1 (es) | 1995-11-28 | 1996-11-27 | Derivados de 2-(sulfanil substituido)-3,5-dihidro-imidazol-4-ona y su uso en la preparacionn de medicamentos. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0876354A1 (es) |
| JP (1) | JP2000514401A (es) |
| AR (1) | AR004781A1 (es) |
| AU (1) | AU1063497A (es) |
| CA (1) | CA2238812A1 (es) |
| WO (1) | WO1997019931A1 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1426046A4 (en) | 2001-09-14 | 2005-11-02 | Shionogi & Co | NEW USE OF TRICYCLIC COMPOUNDS |
| NZ548209A (en) | 2003-12-19 | 2009-07-31 | Univ California | Methods and materials for assessing prostate cancer thearapies |
| US7718684B2 (en) | 2004-02-24 | 2010-05-18 | The Regents Of The University Of California | Methods and materials for assessing prostate cancer therapies and compounds |
| US7709517B2 (en) | 2005-05-13 | 2010-05-04 | The Regents Of The University Of California | Diarylhydantoin compounds |
| SI2656841T1 (sl) | 2006-03-27 | 2016-11-30 | The Regents Of The University Of California | Modulator androgenih receptorjev za zdravljanje raka prostate in bolezni, povezanih z androgenimi receptorji |
| EP3020706A1 (en) | 2006-03-29 | 2016-05-18 | The Regents Of The University Of California | Diarylthiohydantoin compounds useful for the treatment of a hyperproliferative disorder |
| AR069039A1 (es) | 2007-10-26 | 2009-12-23 | Univ California | Compuestos de diarilhidantoina, composicion farmaceutica, proceso de obtencion del compuesto, utiles para desordenes hiperproliferativos |
| LT3124481T (lt) | 2010-02-16 | 2018-06-11 | Aragon Pharmaceuticals, Inc. | Androgeno receptorių moduliatoriai ir jų panaudojimas |
| AU2013323861C1 (en) | 2012-09-26 | 2024-05-02 | Aragon Pharmaceuticals, Inc. | Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer |
| JOP20200097A1 (ar) | 2013-01-15 | 2017-06-16 | Aragon Pharmaceuticals Inc | معدل مستقبل أندروجين واستخداماته |
| TWI726969B (zh) | 2016-01-11 | 2021-05-11 | 比利時商健生藥品公司 | 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物 |
| CN111479560A (zh) | 2017-10-16 | 2020-07-31 | 阿拉贡药品公司 | 用于治疗非转移性去势难治性前列腺癌的抗雄激素 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2694290B1 (fr) * | 1992-07-08 | 1994-09-02 | Roussel Uclaf | Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant. |
| WO1994020460A1 (en) * | 1993-03-11 | 1994-09-15 | Smithkline Beecham Corporation | Chemical compounds |
| US5554607A (en) * | 1995-11-28 | 1996-09-10 | American Home Products Corporation | Use of 2-thioxo-imidazolin-4-one derivatives in the treatment of atherosclerosis |
-
1996
- 1996-11-25 CA CA002238812A patent/CA2238812A1/en not_active Abandoned
- 1996-11-25 JP JP09520711A patent/JP2000514401A/ja active Pending
- 1996-11-25 AU AU10634/97A patent/AU1063497A/en not_active Abandoned
- 1996-11-25 EP EP96941513A patent/EP0876354A1/en not_active Withdrawn
- 1996-11-25 WO PCT/US1996/019108 patent/WO1997019931A1/en not_active Ceased
- 1996-11-27 AR ARP960105365A patent/AR004781A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2238812A1 (en) | 1997-06-05 |
| EP0876354A1 (en) | 1998-11-11 |
| WO1997019931A1 (en) | 1997-06-05 |
| JP2000514401A (ja) | 2000-10-31 |
| AU1063497A (en) | 1997-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR004781A1 (es) | Derivados de 2-(sulfanil substituido)-3,5-dihidro-imidazol-4-ona y su uso en la preparacionn de medicamentos. | |
| MEP24608A (en) | Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same | |
| DK1169298T3 (da) | Farmaceutiske forbindelser | |
| CY1109153T1 (el) | Ενωσεις υποκατεστημενου κυκλοπεντανιου και κυκλοπεντενιου χρησιμες ως αναστολεις νευραμινιδασης | |
| ES2158284T3 (es) | Metil-fenil-oxazolidinonas quirales. | |
| ES2173477T3 (es) | Derivados de tetrahidronaftaleno y su utilizacion terapeutica. | |
| FI963169A0 (fi) | Enkefalinaasin ja ACE:n inhibittoreina käyttökelpoisia uusia merkaptoasetyyliamido-1,3,4,5-tetrahydrobents/c/-atsepin-3-onidisulfidijohdannaisia | |
| DE69728544D1 (de) | Totalsynthese von acylfulvenen mit antitumorwirkung | |
| ATE24001T1 (de) | Substituierte 1-hydroxyethyl-triazolyl-derivate. | |
| DE69204041D1 (de) | Thiazolidinverbindeungen, deren Herstellung und therapeutische Verwendung. | |
| ES557664A0 (es) | Un procedimiento para la sintesis de derivados de imidazol. | |
| NO971789D0 (no) | Di-tert-butylfenolforbindelser med heterocyklisk enhet for anvendelse som antiinflammatoriske midler | |
| AR025951A1 (es) | Derivados de 4-hicroxibifenil hidrazidas y métodos para preparar los derivados. | |
| CO5150179A1 (es) | Derivados de n-etilpirimidin o (piridin)-2-(1,2-benzoisoxa- zol-3-il)-octahidro-2h-pirido[1,2-a]pirazina y sus composiciones farmaceuticas | |
| SE9904674D0 (sv) | Novel compounds | |
| AR004691A1 (es) | Nuevos derivados de [3-alcoxi-fenoxi-)-etil]-dialquilamina, una composicion farmaceutica que los comprende, su uso como anestesicos locales y unprocedimiento para su preparacion | |
| DK0490816T3 (da) | Fluorforbindelser som aromatase-inhibitorer. | |
| ITMI920084A1 (it) | Alchil derivati del trazodone | |
| ES2045197T3 (es) | N-substituidos-n-nitroso-aminoacetonitrilos, procedimiento para su fabricacion y utilizacion. | |
| ITMI922659A0 (it) | Procedimento per la preparazione di paraffine solfonate ad alto contenuto di polisolfonati | |
| DK0379414T3 (da) | Derivater af 1,8-benzonaphthyridin og fremstilling deraf | |
| BR9912885A (pt) | Derivado de 3-azabiciclo-[3.2.0]- heptano n-substituìdo | |
| IT1273987B (it) | Uso di esteri ftalidilidenici della carnitina e di alcanoil carnitine per il trattamento dello shock endotossico | |
| AU545800B2 (en) | New compounds | |
| AR004779A1 (es) | Derivados de 2-tioxo-imidazolidin-4-ona |